The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial

[1]  D. Fenton,et al.  Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients , 2017, Journal of the American Academy of Dermatology.

[2]  S. Hilsenbeck,et al.  Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial , 2017, JAMA.

[3]  Hyoseung Shin,et al.  Efficacy of interventions for prevention of chemotherapy‐induced alopecia: A systematic review and meta‐analysis , 2015, International journal of cancer.

[4]  A. Collett,et al.  Use of in vitro human keratinocyte models to study the effect of cooling on chemotherapy drug-induced cytotoxicity. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  K. Friedrichs,et al.  Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling , 2014, SpringerPlus.

[6]  Y. Im,et al.  Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  J. Coebergh,et al.  Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia , 2014, Acta oncologica.

[8]  S. Kitano,et al.  DHL‑TauZnNa, a newly synthesized α-lipoic acid derivative, induces autophagy in human colorectal cancer cells. , 2013, Oncology reports.

[9]  G. Romieu,et al.  Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  G. Romieu,et al.  Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients. , 2012 .

[11]  S. Chon,et al.  Chemotherapy-induced alopecia. , 2012, Journal of the American Academy of Dermatology.

[12]  S. Kitano,et al.  Antiproliferative effects of a new α-lipoic acid derivative, DHL-HisZnNa, in HT29 human colon cancer cells in vitro , 2012, Expert opinion on therapeutic targets.

[13]  S. Kitano,et al.  The α-Lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: A pilot study , 2011, Surgery Today.

[14]  Andreas Schneeweiss,et al.  Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Prevezas,et al.  Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer , 2009, The British journal of dermatology.

[16]  A. Vingerhoets,et al.  Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations , 2009, Supportive Care in Cancer.

[17]  Louise Provencher,et al.  Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review , 2008, Psycho-oncology.

[18]  M. Casiraghi,et al.  A case-control study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopecia. , 2007, Minerva medica.

[19]  V. Botchkarev.  Molecular mechanisms of chemotherapy-induced hair loss. , 2003, The journal of investigative dermatology. Symposium proceedings.

[20]  R. Paus,et al.  Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs. , 1998, The Journal of investigative dermatology.

[21]  S. De Flora,et al.  Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice. , 1998, International journal of oncology.

[22]  G. Hortobagyi,et al.  A randomized trial of minoxidil in chemotherapy-induced alopecia. , 1996, Journal of the American Academy of Dermatology.

[23]  B. Sangro,et al.  Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin. , 1986, The New England journal of medicine.

[24]  L. Friberg,et al.  Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man. , 1985, Scandinavian journal of clinical and laboratory investigation.

[25]  S. De Flora,et al.  Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of l-cystine and vitamin B6 , 2012, Archives of Dermatological Research.